Cargando…
Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma
If not detected early, oral squamous cell carcinoma (OSCC) has very poor prognosis, emphasizing the need for reliable early diagnostics. Saliva is considered a promising surrogate biosample for OSCC detection, because it comes into contact with many cells of the tumor mass, providing a comprehensive...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876825/ https://www.ncbi.nlm.nih.gov/pubmed/35215172 http://dx.doi.org/10.3390/pathogens11020229 |
_version_ | 1784658264974163968 |
---|---|
author | Scholtz, Beáta Horváth, József Tar, Ildikó Kiss, Csongor Márton, Ildikó J. |
author_facet | Scholtz, Beáta Horváth, József Tar, Ildikó Kiss, Csongor Márton, Ildikó J. |
author_sort | Scholtz, Beáta |
collection | PubMed |
description | If not detected early, oral squamous cell carcinoma (OSCC) has very poor prognosis, emphasizing the need for reliable early diagnostics. Saliva is considered a promising surrogate biosample for OSCC detection, because it comes into contact with many cells of the tumor mass, providing a comprehensive sampling of tumor-specific biomolecules. Although several protein- and RNA-based salivary biomarkers have been proposed for the detection of OSCC, the results of the studies show large differences. Our goal was to clarify which salivary microRNAs (miRNA) show reliably high expression in the saliva of OSCC patients, to be used as cancer-specific biomarkers, and potentially as early diagnostic biomarkers. Based on a detailed literature search, we selected six miRNAs commonly overexpressed in OSCC, and analyzed their expression in saliva samples of cancer patients and controls by real-time quantitative PCR. Our results suggest that miR-345 and miR-31-5p are consistently upregulated salivary biomarkers for OSCC, and a three-miRNA panel of miR-345, miR-31-5p, and miR-424-3p can distinguish cancer and control patients with high sensitivity. |
format | Online Article Text |
id | pubmed-8876825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88768252022-02-26 Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma Scholtz, Beáta Horváth, József Tar, Ildikó Kiss, Csongor Márton, Ildikó J. Pathogens Article If not detected early, oral squamous cell carcinoma (OSCC) has very poor prognosis, emphasizing the need for reliable early diagnostics. Saliva is considered a promising surrogate biosample for OSCC detection, because it comes into contact with many cells of the tumor mass, providing a comprehensive sampling of tumor-specific biomolecules. Although several protein- and RNA-based salivary biomarkers have been proposed for the detection of OSCC, the results of the studies show large differences. Our goal was to clarify which salivary microRNAs (miRNA) show reliably high expression in the saliva of OSCC patients, to be used as cancer-specific biomarkers, and potentially as early diagnostic biomarkers. Based on a detailed literature search, we selected six miRNAs commonly overexpressed in OSCC, and analyzed their expression in saliva samples of cancer patients and controls by real-time quantitative PCR. Our results suggest that miR-345 and miR-31-5p are consistently upregulated salivary biomarkers for OSCC, and a three-miRNA panel of miR-345, miR-31-5p, and miR-424-3p can distinguish cancer and control patients with high sensitivity. MDPI 2022-02-09 /pmc/articles/PMC8876825/ /pubmed/35215172 http://dx.doi.org/10.3390/pathogens11020229 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Scholtz, Beáta Horváth, József Tar, Ildikó Kiss, Csongor Márton, Ildikó J. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title | Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title_full | Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title_fullStr | Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title_full_unstemmed | Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title_short | Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma |
title_sort | salivary mir-31-5p, mir-345-3p, and mir-424-3p are reliable biomarkers in patients with oral squamous cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876825/ https://www.ncbi.nlm.nih.gov/pubmed/35215172 http://dx.doi.org/10.3390/pathogens11020229 |
work_keys_str_mv | AT scholtzbeata salivarymir315pmir3453pandmir4243parereliablebiomarkersinpatientswithoralsquamouscellcarcinoma AT horvathjozsef salivarymir315pmir3453pandmir4243parereliablebiomarkersinpatientswithoralsquamouscellcarcinoma AT tarildiko salivarymir315pmir3453pandmir4243parereliablebiomarkersinpatientswithoralsquamouscellcarcinoma AT kisscsongor salivarymir315pmir3453pandmir4243parereliablebiomarkersinpatientswithoralsquamouscellcarcinoma AT martonildikoj salivarymir315pmir3453pandmir4243parereliablebiomarkersinpatientswithoralsquamouscellcarcinoma |